172 related articles for article (PubMed ID: 32062078)
21. Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release.
Hecker A; Küllmar M; Wilker S; Richter K; Zakrzewicz A; Atanasova S; Mathes V; Timm T; Lerner S; Klein J; Kaufmann A; Bauer S; Padberg W; Kummer W; Janciauskiene S; Fronius M; Schweda EK; Lochnit G; Grau V
J Immunol; 2015 Sep; 195(5):2325-34. PubMed ID: 26202987
[TBL] [Abstract][Full Text] [Related]
22. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass.
Hiyama A; Takeda J; Kotake Y; Morisaki H; Fukushima K
J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):580-4. PubMed ID: 9263089
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.
Finn A; Naik S; Klein N; Levinsky RJ; Strobel S; Elliott M
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):234-41. PubMed ID: 8429650
[TBL] [Abstract][Full Text] [Related]
24. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
25. Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7.
Hussen J; Düvel A; Koy M; Schuberth HJ
Dev Comp Immunol; 2012 Oct; 38(2):312-20. PubMed ID: 22728096
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities.
Börgermann J; Friedrich I; Flohé S; Spillner J; Majetschak M; Kuss O; Sablotzki A; Feldt T; Reidemeister JC; Schade FU
J Thorac Cardiovasc Surg; 2002 Sep; 124(3):608-17. PubMed ID: 12202878
[TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.
Mezzasoma L; Antognelli C; Talesa VN
Immunol Res; 2016 Feb; 64(1):303-12. PubMed ID: 26616294
[TBL] [Abstract][Full Text] [Related]
28. Alpha 1-antitrypsin does not inhibit human monocyte caspase-1.
Rahman MA; Mitra S; Sarkar A; Wewers MD
PLoS One; 2015; 10(2):e0117330. PubMed ID: 25658455
[TBL] [Abstract][Full Text] [Related]
29. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer.
Xu Y; Zhang J; Han J; Pan X; Cao Y; Guo H; Pan Y; An Y; Li X
Mol Oncol; 2012 Aug; 6(4):405-17. PubMed ID: 22507634
[TBL] [Abstract][Full Text] [Related]
31. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
33. The lipid ties of α1-antitrypsin: Structural and functional aspects.
Segal L; Lewis EC
Cell Immunol; 2022 May; 375():104528. PubMed ID: 35468329
[TBL] [Abstract][Full Text] [Related]
34. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
35. Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin.
Tumpara S; Gründing AR; Sivaraman K; Wrenger S; Olejnicka B; Welte T; Wurm MJ; Pino P; Kiseljak D; Wurm FM; Janciauskiene S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360706
[TBL] [Abstract][Full Text] [Related]
36. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
[TBL] [Abstract][Full Text] [Related]
37. α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages.
Bai X; Bai A; Tomasicchio M; Hagman JR; Buckle AM; Gupta A; Kadiyala V; Bevers S; Serban KA; Kim K; Feng Z; Spendier K; Hagen G; Fornis L; Griffith DE; Dzieciatkowska M; Sandhaus RA; Gerber AN; Chan ED
J Immunol; 2022 Nov; 209(9):1746-1759. PubMed ID: 36162872
[TBL] [Abstract][Full Text] [Related]
38. YopM of Yersinia enterocolitica specifically interacts with alpha1-antitrypsin without affecting the anti-protease activity.
Heusipp G; Spekker K; Brast S; Fälker S; Schmidt MA
Microbiology (Reading); 2006 May; 152(Pt 5):1327-1335. PubMed ID: 16622050
[TBL] [Abstract][Full Text] [Related]
39. Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro?
Persson C; Subramaniyam D; Stevens T; Janciauskiene S
Chest; 2006 Jun; 129(6):1683-92. PubMed ID: 16778290
[TBL] [Abstract][Full Text] [Related]
40. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
